Conceivable has developed the world’s first AI-powered automated IVF lab. Our reinvention of today’s largely manual, artisanal labs delivers new levels of precision, quality, and scalability. AURA’s integrated platform performs all IVF lab functions, including: dish preparation, sperm processing, egg discovery and preparation, ICSI, incubation, vitrification and thawing. 18% of adults are affected by infertility. 95% are unable to access IVF. Conceivable optimizes safety, maintains consistency, and maximizes success at scale, bringing this Nobel prize winning therapy to the many. In an IRB approved proof of concept study using AURA prototypes, 21 pregnancies were achieved with a success rate comparable to the world’s top-performing fertility clinics. AURA is in clinical operations in Mexico City, inclusive of an IRB-approved 100-patient pilot study. To date, the company has raised $70 million.
| Website | https://www.conceivable.life |
| Revenue | $15 million |
| Employees | 89 (59 on RocketReach) |
| Founded | 2022 |
| Address | 160 Mercer Street, New York, New York 10012, US |
| Industry | Biotechnology Research |
| Keywords | Ivf Technology, In Vitro Fertilization, Fertility Technology, Assisted Reproductive Technology, Fertility Clinic Technology, Reproductive Medicine, Fertility Solutions, Automated Lab, Lab Automation, Medical Technology, Healthcare Technology |
| Competitors | Natera, CooperSurgical, Invitae, Maven Clinic, CCRM Fertility, MediNatura Inc., Modern Fertility, Reprogenetics, LLC (Preimplantation Genetic Diagnosis), Fairygodboss, OvaScience +26 more (view full list) |
Looking for a particular Conceivable Life Sciences employee's phone or email?
The Conceivable Life Sciences annual revenue was $15 million in 2026.
Alan Murray is the Founder and Co-CEO of Conceivable Life Sciences.
59 people are employed at Conceivable Life Sciences.
Conceivable Life Sciences is based in New York, New York.